I am reading thru vernakalant's history,apparently the IV recieved a panel recommendation a few years ago but FDA would not approve without an additional trial,and then apparently a death stopped further progress ,since the IV is approved in europe and latin america i wonder if any data collected from those countries could be used to restart US IV application.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.